# Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia

> **NCT00049075** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 128 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** fludarabine phosphate

## Key facts

- **NCT ID:** NCT00049075
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08-08
- **Primary completion:** 2005-07-22
- **Final completion:** 2009-12-21
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2020-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049075, "Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00049075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*